Systematic identification of functionally relevant risk alleles to stratify aggressive versus indolent prostate cancer

Por Nowinski, Salpie, Santaolalla, Aida, O’Leary, Ben, Loda, Massimo, Mirchandani, Ayesha, Emberton, Mark, Van Hemelrijck, Mieke, Grigoriadis, Anita
Publicado no Oncotarget (2018)

Reproducibility of Digital PCR Assays for Circulating Tumor DNA Analysis in Advanced Breast Cancer

Por Hrebien, Sarah, O’Leary, Ben, Beaney, Matthew, Schiavon, Gaia, Fribbens, Charlotte, Bhambra, Amarjit, Johnson, Richard, Garcia-Murillas, Isaac, Turner, Nicholas
Publicado no PLoS One (2016)

COVID-19: A Catalyst for Change for UK Clinical Oncology

Por Coles, Charlotte Elizabeth, Choudhury, Ananya, Hoskin, Peter J., Jones, Christopher M., O’Leary, Ben, Roques, Tom W., Tharmalingam, Hannah, Yuille, Frances A.P.
Publicado no Int J Radiat Oncol Biol Phys (2020)

Tracking evolution of aromatase inhibitor resistance with circulating tumour DNA analysis in metastatic breast cancer

Por Fribbens, Charlotte, Garcia Murillas, Isaac, Beaney, Matthew, Hrebien, Sarah, O’Leary, Ben, Kilburn, Lucy, Howarth, Karen, Epstein, Michael, Green, Emma, Rosenfeld, Nitzan, Ring, Alistair, Johnston, Stephen, Turner, Nicholas
Publicado no Ann Oncol (2018)

Circulating Tumor DNA Markers for Early Progression on Fulvestrant With or Without Palbociclib in ER+ Advanced Breast Cancer

Por O’Leary, Ben, Cutts, Rosalind J, Huang, Xin, Hrebien, Sarah, Liu, Yuan, André, Fabrice, Loibl, Sibylle, Loi, Sherene, Garcia-Murillas, Isaac, Cristofanilli, Massimo, Bartlett, Cynthia Huang, Turner, Nicholas C
Publicado no J Natl Cancer Inst (2020)

The genetic landscape and clonal evolution of breast cancer resistance to palbociclib plus fulvestrant in the PALOMA-3 trial

Por O’Leary, Ben, Cutts, Rosalind J, Liu, Yuan, Hrebien, Sarah, Huang, Xin, Fenwick, Kerry, André, Fabrice, Loibl, Sibylle, Loi, Sherene, Garcia-Murillas, Isaac, Cristofanilli, Massimo, Huang Bartlett, Cynthia, Turner, Nicholas C
Publicado no Cancer Discov (2018)

Early circulating tumor DNA dynamics and clonal selection with palbociclib and fulvestrant for breast cancer

Por O’Leary, Ben, Hrebien, Sarah, Morden, James P., Beaney, Matthew, Fribbens, Charlotte, Huang, Xin, Liu, Yuan, Bartlett, Cynthia Huang, Koehler, Maria, Cristofanilli, Massimo, Garcia-Murillas, Isaac, Bliss, Judith M., Turner, Nicholas C.
Publicado no Nat Commun (2018)

ESR1 mutations in metastatic lobular breast cancer patients

Por Desmedt, Christine, Pingitore, Julien, Rothé, Françoise, Marchio, Caterina, Clatot, Florian, Rouas, Ghizlane, Richard, François, Bertucci, François, Mariani, Odette, Galant, Christine, Fribbens, Charlotte, O’Leary, Ben, van den Eynden, Gert, Salgado, Roberto, Turner, Nicholas C., Piccart, Martine, Vincent-Salomon, Anne, Pruneri, Giancarlo, Larsimont, Denis, Sotiriou, Christos
Publicado no NPJ Breast Cancer (2019)

Ultra-sensitive mutation detection and genome-wide DNA copy number reconstruction by error corrected circulating tumor DNA sequencing

Por Mansukhani, Sonia, Barber, Louise J., Kleftogiannis, Dimitrios, Moorcraft, Sing Yu, Davidson, Michael, Woolston, Andrew, Proszek, Paula Zuzanna, Griffiths, Beatrice, Fenwick, Kerry, Herman, Bram, Matthews, Nik, O’Leary, Ben, Hulkki, Sanna, Gonzalez De Castro, David, Patel, Anisha, Wotherspoon, Andrew, Okachi, Aleruchi, Rana, Isma, Begum, Ruwaida, Davies, Matthew N., Powles, Thomas, von Loga, Katharina, Hubank, Michael, Turner, Nick, Watkins, David, Chau, Ian, Cunningham, David, Lise, Stefano, Starling, Naureen, Gerlinger, Marco
Publicado no Clin Chem (2018)